Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Berry

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Endocrinology|November 1, 1990
Localization and growth hormone (GH)-releasing activity of rat testicular GH-releasing hormone-like peptideO H Pescovitz, S A Berry, M Laudon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 1995
3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylaseW Röschinger, D S Millington, D A Gage, et al.
Metabolism: Clinical and Experimental|January 1, 1989
Effects of elevated serum insulinlike growth factor-II on growth hormone and insulinlike growth factor-I mRNA and secretionD M Wilson, S N Perkins, J A Thomas, et al.
Neurology|December 31, 1997
Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutationsI D Wexler, S G Hemalatha, J McConnell, et al.
Human Molecular Genetics|November 5, 1999
CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasiaG Zhou, Y Chen, L Zhou, et al.
Journal of Clinical Pharmacology|June 19, 2013
Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disordersJon P R Monteleone, M Mokhtarani, G A Diaz, et al.
Molecular Genetics and Metabolism Reports|June 27, 2017
Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrateM Mokhtarani, G A Diaz, U Lichter-Konecki, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
HIV Medicine|December 19, 2018
Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research NetworkD C Griffith, C Farmer, K A Gebo, et al.
Human Gene Therapy|March 1, 1996
Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II)C B Whitley, R S McIvor, E L Aronovich, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Endocrinology|November 1, 1990
Localization and growth hormone (GH)-releasing activity of rat testicular GH-releasing hormone-like peptideO H Pescovitz, S A Berry, M Laudon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 1995
3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylaseW Röschinger, D S Millington, D A Gage, et al.
Metabolism: Clinical and Experimental|January 1, 1989
Effects of elevated serum insulinlike growth factor-II on growth hormone and insulinlike growth factor-I mRNA and secretionD M Wilson, S N Perkins, J A Thomas, et al.
Neurology|December 31, 1997
Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutationsI D Wexler, S G Hemalatha, J McConnell, et al.
Human Molecular Genetics|November 5, 1999
CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasiaG Zhou, Y Chen, L Zhou, et al.
Journal of Clinical Pharmacology|June 19, 2013
Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disordersJon P R Monteleone, M Mokhtarani, G A Diaz, et al.
Molecular Genetics and Metabolism Reports|June 27, 2017
Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrateM Mokhtarani, G A Diaz, U Lichter-Konecki, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
HIV Medicine|December 19, 2018
Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research NetworkD C Griffith, C Farmer, K A Gebo, et al.
Human Gene Therapy|March 1, 1996
Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II)C B Whitley, R S McIvor, E L Aronovich, et al.
Pageof 10